Navigation Links
Direct-to-Slide Printer Now Offers High-Performance Ink Ribbons

PLYMOUTH, Minn., June 25, 2013 /PRNewswire/ -- Specimen misidentification on slides can be a major risk in lab operations due to the difficulty of reading handwritten patient data or the use of difficult-to-apply xylene-resistant labels. That's why direct-to-slide printers such as Primera's Signature Slide Printer have recently become popular in laboratories all over the world.


Primera's original ribbons for its Signature Slide Printer offered an acceptable degree of resistance to the chemicals typically found in pathology and histology labs. However, more rigorous procedures in some processing equipment demanded even tougher inks. Primera has responded to this need with its most chemical, temperature and abrasion-resistant ribbons ever. Called TuffCoat 2 (TC2), these new ribbon formulations were specifically developed to deliver superior performance in pathology, histology, cytology and other types of laboratory applications.

Key features and benefits of TC2 ribbons include:

  • Available in black monochrome and CMYK
  • Highly heat and chemical-resistant, even if touched while wet with chemicals such as xylene or acetone
  • Instantly dry and permanent – no heat, fans or IR light treatment is necessary
  • Works on a much wider variety of commonly-used slides and brands
  • Lower heat and print head pressure – contributes to superior reliability and longer intervals between print head replacement

"Signature Slide Printer has quickly built a reputation as a reliable, fully-featured instrument at a reasonable cost," said Mark D. Strobel, Primera's vice president of sales and marketing. "Now, our users can be more confident than ever that when text and bar codes are printed onto slides, those images are really going to be permanent."

Find out more about Primera Technology's range of laboratory identification products at Watch a product video at

About Primera Technology
Headquartered in Plymouth, Minnesota, USA, Primera Technology, Inc. is one of the world's leading specialty printer manufacturers. Its products are sold worldwide through Primera Authorized Resellers and Distributors in more than 167 countries.

More information about Primera's healthcare products is available online at or by calling 1-800-797-2772 (USA and Canada). Outside of the USA and Canada, call (763) 475-6676 or FAX (763) 475-6677. E-mail to

For Europe, Scandinavia, Middle East and Africa, contact Primera Europe GmbH in Germany by phone at +49-(0) 611-92777-0, by FAX at +49-(0) 611-92777-50 or by e-mail at

For Asia Pacific, contact Primera Asia Pacific in Australia by phone at +61 3 8586 3030 or by email at

For Latin America, contact Primera Latin America in Brazil by phone at +55 11 26 26 80 17, by FAX at +55 11 39 58 04 88 or by email at

Notes to Editors:  Primera is a registered trademark of Primera Technology, Inc.  All other trademarks are the property of their respective companies.

SOURCE Primera Technology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ricoh unveils MFPs and printers engineered for healthcare
2. OKI Europe Launches Cost-effective DICOM-embedded LED Printer Range - a First for Medical Imaging and Printing
3. Team U.S.A. Amputee Sprinter Wins 100 Meter Paralympic Silver Medal
4. Andrews Institute offers innovative technology for spine surgery
5. Philips IMR offers new capabilities to simultaneously reduce CT Radiation and enhance image quality
6. Fuse Science Round II Research Offers Major Advancements in Delivery of Active Pharmaceutical Ingredients
7. New Prefillable Syringe System Offers Advanced Glass Technology for Biopharmaceutical Injectable Drug Delivery
8. New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines
9. Apexus Answers Offers New Service: Live Scheduled 340B Group Chat
10. Family Tree DNA Offers mtDNA Test For $49
11. CVS Caremark Offers Advice on Proper Management, Storage and Disposal of Medications in Light of New Study on Teen Abuse of Prescription Drugs
Post Your Comments:
(Date:11/26/2015)... ) has announced ... High Viscosity Drugs" report to their offering. ... addition of the "Self Administration of High ... --> Research and Markets ( ) ... Administration of High Viscosity Drugs" report to ...
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, a ... treatment outcomes for patients suffering from chronic pain, said ... a Temporary Restraining Order (TRO) enjoining Express Scripts from ... companies. --> --> ... of its legal options. --> ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an ... changing the way that they are handling security in light of the recent terrorist ... presence in an attempt to stop an attack from reaching U.S. soil. Especially around ...
(Date:11/27/2015)... ... 27, 2015 , ... "When I was traveling, I was ... N.J. "Many people catch diseases simply from sitting on such dirty toilet seats. ... from germs." , He developed the patent-pending QUDRATECS to eliminate the need to ...
(Date:11/27/2015)... ... ... the No.1 Herpes-only dating community in the world, revealed that over 50% of its members ... billion people under the age of 50 – or 67% of the population - are ... of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, Co-Founder ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... failing. Secura Consultants has prided itself for not only fulfilling the needs of ... protection solutions at an affordable price and providing top-tier customer service. However, there's ...
(Date:11/27/2015)... ... November 27, 2015 , ... Dr. Thomas Dunlap ... Inc. and Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph Health ... both STEMI and Sepsis conditions present in similar ways and require time-critical intervention to ...
Breaking Medicine News(10 mins):